Age intrinsic loss of telomere protection via TRF1 reduction in endothelial cells

Philipp J. Hohensinner(Ludwig Boltzmann Institute for Age Research), Johann Wojta(Medical University of Vienna), Gerald Maurer(European Society of Radiology), Svitlana Demyanets(Medical University of Vienna), Elisabeth Buchberger(Medical University of Vienna), B. Ebenbauer(Ludwig Boltzmann Institute for Cardiovascular Research), Kurt Huber(Sigmund Freud Privatuniversität Wien), Ihor Huk(University of Vienna), Christoph Kaun(University of Vienna), Wolfgang Eppel(Medical University of Vienna)
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
December 1, 2015
10.1016/j.bbamcr.2015.11.034
Cited by 67

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755